Skip to content
healthcare.dev

Imatinib Mesylate

NDC 42292-043, imatinib, tablet, film coated, from Mylan Institutional Inc.

Product NDC
42292-043
Status
Listed
Labeler
Mylan Institutional Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204644
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42292-043 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE100 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
42292-043-034229200430330 BLISTER PACK in 1 CARTON (42292-043-03) / 1 TABLET, FILM COATED in 1 BLISTER PACK (42292-043-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1debf3a0-7587-47d7-8ea6-e739698d7297
  • NADAC price for package 42292004303

    GET /v1/drugs/nadac/42292004303

Use it

Look up 42292-043 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42292-043 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42292-043. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.